Belite Bio (BLTE) Research & Development (2022 - 2026)

Belite Bio's Research & Development history runs 5 years deep, the most recent figure standing at $15.7 million for Q1 2026.

• In Q1 2026, Research & Development rose 66.68% year-over-year to $15.7 million; the TTM figure through Mar 2026 stood at $36.0 billion (up 55.26% YoY), while the FY2025 annual figure was $45.4 million, up 51.56% from the prior year.
• Research & Development was $15.7 million for Q1 2026 at Belite Bio, down from $14.6 billion in the prior quarter.
• In the past five years, Research & Development ranged from a high of $14.6 billion in Q4 2025 to a low of $4.9 million in Q4 2023.
• Historically, Research & Development has averaged $5.0 billion across 5 years, with a median of $5.6 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Research & Development surged 149097.86% in 2024, then slumped 99.86% in 2025.
• A 5-year view of Research & Development shows it stood at $5.2 million in 2022, then dropped by 6.97% to $4.9 million in 2023, then soared by 149097.86% to $7.3 billion in 2024, then jumped by 101.6% to $14.6 billion in 2025, then plunged by 99.89% to $15.7 million in 2026.
• The last three Research & Development figures came in at $15.7 million (Q1 2026), $14.6 billion (Q4 2025), and $10.3 billion (Q3 2025), per Business Quant data.